Want to see ANIP full AI Analyst Report?
ANI Pharmaceuticals (ANIP) Ownership Overview
7.96% Insiders
19.67% Mutual Funds
0.30% Other Institutional Investors
23.85% ETFs
48.22% Public Companies and
Individual Investors
The ownership structure of ANI Pharmaceuticals (ANIP) stock is a mix of institutional, retail, and individual investors. Approximately 43.82% of the company’s stock is owned by Institutional Investors, 7.96% is owned by Insiders, and 48.22% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 13, 2026 | xxxxxxxxxxxxx | $36357 | |
May 13, 2026 | xxxxxxxxxxxxx | $4266350 | |
May 13, 2026 | xxxxxxxxxxxxx | $220374 | |
May 13, 2026 | xxxxxxxxxxxxx | $1127120 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $208399 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $4037250 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $1199640 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $6386545 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,151,661 | Institution | 9.46% | 176,586,818 | |
| 1,069,266 | Institution | 4.70% | 87,754,661 | |
| 802,573 | Institution | 3.53% | 65,867,166 | |
| 726,165 | Institution | 3.19% | 59,596,362 | |
| 667,981 | Institution | 2.94% | 54,821,201 | |
| 537,976 | Insider | 2.37% | 44,151,690 | |
| 532,394 | Institution | 2.34% | 43,693,576 | |
| 445,521 | Institution | 1.96% | 36,563,908 | |
| 349,889 | Insider | 1.54% | 28,715,390 | |
| 301,651 | Institution | 1.33% | 24,756,498 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 802,573 | Institution | 3.53% | 65,867,166 | |
| 726,165 | Institution | 3.19% | 59,596,362 | |
| 253,609 | Institution | 1.12% | 20,813,691 | |
| 204,055 | Institution | 0.90% | 16,746,794 | |
| 197,476 | Institution | 0.87% | 16,206,855 | |
| 181,447 | Institution | 0.80% | 14,891,355 | |
| 144,188 | Institution | 0.63% | 11,833,509 | |
| 139,524 | Institution | 0.61% | 11,450,735 | |
| 122,741 | Institution | 0.54% | 10,073,354 | |
| 115,275 | Institution | 0.51% | 9,460,619 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,095,926 | Institution | 4.82% | 89,942,647 | |
| 600,933 | Institution | 2.64% | 47,179,250 | |
| 537,851 | Institution | 2.37% | 44,141,432 | |
| 454,960 | Institution | 2.00% | 38,116,549 | |
| 203,460 | Institution | 0.89% | 15,973,645 | |
| 190,151 | Institution | 0.84% | 15,605,693 | |
| 170,006 | Institution | 0.75% | 13,952,392 | |
| 169,457 | Institution | 0.75% | 14,197,107 | |
| 117,734 | Institution | 0.52% | 9,662,429 | |
| 114,253 | Institution | 0.50% | 9,376,744 |
FAQ
Who Owns Ani Pharmaceuticals (ANIP)?
According to the latest TipRanks data, approximately 0.30% of the company's stock is held by institutional investors, 7.96% is held by insiders, and 48.22% is held by retail investors.
What percentage of Ani Pharmaceuticals (ANIP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.30% of Ani Pharmaceuticals (ANIP) stock is held by institutional investors.
What percentage of Ani Pharmaceuticals (ANIP) stock is held by retail investors?
According to the latest TipRanks data, approximately 48.22% of Ani Pharmaceuticals (ANIP) stock is held by retail investors.
Who owns the most shares of Ani Pharmaceuticals (ANIP)?
iShares owns the most shares of Ani Pharmaceuticals (ANIP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.